KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Invested Capital (2016 - 2025)

Resmed's Return on Invested Capital history spans 16 years, with the latest figure at 0.22% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.22%; the TTM value through Dec 2025 reached 0.22%, up 1.0%, while the annual FY2025 figure was 0.23%, 4.0% up from the prior year.
  • Return on Invested Capital reached 0.22% in Q4 2025 per RMD's latest filing, up from 0.22% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.22% in Q4 2025 to a low of 0.13% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 0.18%, with a median of 0.18% recorded in 2022.
  • The largest YoY upside for Return on Invested Capital was 8bps in 2021 against a maximum downside of -6bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.14% in 2021, then rose by 24bps to 0.17% in 2022, then dropped by -6bps to 0.16% in 2023, then surged by 32bps to 0.22% in 2024, then increased by 4bps to 0.22% in 2025.
  • Per Business Quant, the three most recent readings for RMD's Return on Invested Capital are 0.22% (Q4 2025), 0.22% (Q3 2025), and 0.22% (Q2 2025).